David Hillus

Berlin, BE 13353, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B.

Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis B.

Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026

Community-acquired pneumonia in diabetic patients is characterised by a distinct pathogen spectrum and enhanced inflammation: results from CAPNETZ, a prospective observational cohort study.

Community-acquired pneumonia in diabetic patients is characterised by a distinct pathogen spectrum and enhanced inflammation: results from CAPNETZ, a prospective observational cohort study.

Journal: Infection
Published: August 17, 2025

Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.

Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study.

Journal: The Lancet. Infectious diseases
Published: October 03, 2024

Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: monitoring cardiovascular safety of COVID-19 vaccination.

Levels of high-sensitive troponin T and mid-regional pro-adrenomedullin after COVID-19 vaccination in vulnerable groups: monitoring cardiovascular safety of COVID-19 vaccination.

Journal: Frontiers in cardiovascular medicine
Published: May 19, 2024

Vaccinations as a key to pandemic management - Lessons learned from the COVID-19 pandemic

Vaccinations as a key to pandemic management - Lessons learned from the COVID-19 pandemic

Journal: Deutsche medizinische Wochenschrift (1946)
Published: December 05, 2023

Rewired type I IFN signaling is linked to age-dependent differences in COVID-19.

Rewired type I IFN signaling is linked to age-dependent differences in COVID-19.

Journal: Cell reports. Medicine
Published: September 23, 2023

The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation.

The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation.

Journal: Cell
Published: July 24, 2023

Interoperable, Domain-Specific Extensions for the German Corona Consensus (GECCO) COVID-19 Research Data Set Using an Interdisciplinary, Consensus-Based Workflow: Data Set Development Study.

Interoperable, Domain-Specific Extensions for the German Corona Consensus (GECCO) COVID-19 Research Data Set Using an Interdisciplinary, Consensus-Based Workflow: Data Set Development Study.

Journal: JMIR medical informatics
Published: January 04, 2023

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.

Journal: JCI insight
Published: November 04, 2022

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.

Journal: JAMA
Published: October 10, 2022

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage.

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage.

Journal: The Lancet. Infectious diseases
Published: August 03, 2022

A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021.

A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021.

Journal: medRxiv : the preprint server for health sciences
Published: June 06, 2022
Showing 1-12 of 23

Last Updated: 09/26/2026